These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18382350

  • 1. Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH).
    Fischer I, de la Cruz C, Rivera AL, Aldape K.
    Diagn Mol Pathol; 2008 Dec; 17(4):227-30. PubMed ID: 18382350
    [Abstract] [Full Text] [Related]

  • 2. Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study.
    Yoo SB, Lee HJ, Park JO, Choe G, Chung DH, Seo JW, Chung JH.
    Lung Cancer; 2010 Mar; 67(3):301-5. PubMed ID: 19505745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T, Hirato J, Nakazato Y.
    Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM.
    Quezado M, Ronchetti R, Rapkiewicz A, Santi M, Blumenthal DT, Rushing EJ.
    Clin Neuropathol; 2005 Apr; 24(4):163-9. PubMed ID: 16033132
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.
    Zhao J, Wu R, Au A, Marquez A, Yu Y, Shi Z.
    Mod Pathol; 2002 Jun; 15(6):657-65. PubMed ID: 12065780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
    El-Zammar OA, Zhang S, Katzenstein AL.
    Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of HER2 by chromogenic in situ hybridization and immunohistochemistry in lymph node-negative breast carcinoma: Prognostic relevance.
    Peiró G, Aranda FI, Adrover E, Niveiro M, Alenda C, Payá A, Seguí J.
    Hum Pathol; 2007 Jan; 38(1):26-34. PubMed ID: 17056098
    [Abstract] [Full Text] [Related]

  • 19. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
    Okada Y, Hurwitz EE, Esposito JM, Brower MA, Nutt CL, Louis DN.
    Cancer Res; 2003 Jan 15; 63(2):413-6. PubMed ID: 12543796
    [Abstract] [Full Text] [Related]

  • 20. Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome.
    Francis GD, Jones MA, Beadle GF, Stein SR.
    Diagn Mol Pathol; 2009 Jun 15; 18(2):88-95. PubMed ID: 19430296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.